NTRK1 and cancer: Nonetheless, cancer cells often adapt to the treatments and develop resistance through mechanisms such as mutation, amplification, or loss of the target; expression of multidrug efflux pumps; activation of receptor tyrosine kinases; compensatory signaling of alternate pathways; and tumor microenvironment-mediated changes in signaling activities of cancer cells [8].